FDA | Tokio X'press - Part 2

Biogen Plans Regulatory Filing for Aducanumab in Alzheimer’s Disease Based on New Analysis of Larger Dataset from Phase 3 Studies

Tuesday November 5th, 2019By Tokio X'press FDA, Pharmaceutical

Kyowa Kirin Announces FDA Approval of NOURIANZTM (istradefylline) for Use in Parkinson’s Disease

Sunday September 1st, 2019By Tokio X'press FDA, Pharmaceutical

FDA calls out Juul and Altria for backing off promises to fight teen vaping

Monday February 11th, 2019By Tokio X'press TOBACCO, health, FDA

FDA approves over-the-counter hearing aid from Bose

Saturday October 6th, 2018By Tokio X'press Medical care, FDA

FDA Bans Use of 7 Synthetic Food Additives After Environmental Groups Sue

Sunday October 7th, 2018By Tokio X'press FDA, Regulation